Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Results of the JBI cross-sectional survey bias risk assessment_
| Inclusion in the study | Rationale for the title | Population selection | Exclusion criteria | Sample characteristics | Instrument reliability and validity tests | Veracity | Ethical principles | Statistical methods Study | Study results | Study value | Total score |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ngo et al.21 | ② | ① | ② | ① | ① | ② | ② | ② | ② | ② | 17 |
| Bournival et al.22 | ② | ① | ① | ① | NA | ② | ① | ② | ② | ② | 14 |
| Al Ammari et al.23 | ② | ① | ① | ① | NA | ② | ② | ② | ② | ② | 15 |
| Castel-Branco et al.24 | ② | ① | ① | ① | NA | ② | ② | ② | ② | ② | 15 |
| Pothirat et al.8 | ② | ① | ① | ① | NA | ② | ② | ② | ② | ② | 15 |
| Ding et al.25 | ② | ① | ① | ① | NA | ② | NA | ② | ② | ② | 13 |
| Press et al.26 | ② | ① | ① | ① | ① | ② | ② | ② | ② | ② | 16 |
Results of risk of bias evaluation of the included literature by NOS score_
| Inclusion of studies | Study population selection | Comparability of results | Evaluation of outcomes |
|---|---|---|---|
| Loukil et al.16 | *** | ** | ** |
| Gillissen et al.17 | **** | ** | ** |
| Lin et al.18 | ** | ** | ** |
| Li et al.19 | ** | ** | *** |
| Takaku et al.20 | *** | ** | ** |
Clinical characteristics of included trials_
| Inclusion of studies | Type of study | Country | Percentage of women (%) | Age (years) mean (+SD/range) | Total number of people (n) | Type of inhaler used |
|---|---|---|---|---|---|---|
| Loukil et al16 | Cohort | Spanish | 48.2 | 47.4 ± 16.3 | 54 | DPI |
| Gillissen et al.17 | Cohort | Germany | 44.6 | 65.6 ± 11.6 | 1236 | DPI |
| Lin et al18 | Cohort | China | 36.8 | 67 ± 15 | 136 | DPI, MDI |
| Li et al.19 | Cohort | China | 33.1 | 64 (47–81) | 384 | DPI |
| Takaku et al.20 | Cohort | Japan | 9.0 | 72 ± 7 | 81 | MDI, DPI |
| Ngo et al21 | Cross-sectional | Vietnam | 7.0 | 68.6 ± 8.7 | 70 | MDI, DPI, SMI |
| Bournival et al.22 | Cross-sectional | Canada | 49.0 | 69.8 ± 8.3 | 98 | DPI, SMI |
| Al Ammari et al.23 | Cross-sectional | Saudi Arabia | 48.9 | 58.4 ± 17.9 | 40 | MDI |
| Castel-Branco et al.24 | Cross-Sectional | Portugal | 49.3 | 65.4 ± 18.38 | 95 | DPI, MDI, SMI |
| Pothirat et al.8 | Cross-sectional | Thailand | 35.9 | 71.2 ± 9.2 | 103 | DPI, MDI, SMI |
| Ding et al.25 | Cross-sectional | America | 48.0 | Men: 59.8 ± 10.2; Women: 60.7 ± 7.8 | 61 | MDI, SMI |
| Press et al.26 | Cross-Sectional | America | 58.6 | 59.2 | 29 | MDI |
| Oliveira et al.27 | RCT | Brazil | 44.0 | 63.5 ± 8.2 | 140 | DPI, SMI |